Canada’s Proposed Legislation to Prohibit Cross-Border Price Differentials
March 26, 2014
No Comments
This article is part of a Chronicle. See more from this Chronicle Marissa Ginn, Marc Van Audenrode, Mar 26, 2014
Marissa Ginn
Dr. Ginn specializes in applying microeconomic and econometric techniques to construct complete analyses in both litigation and non-litigation contexts. She has led large teams in antitrust, commercial damages, and intellectual property cases in several industries, including chemicals, telecommunications, finance, pharmaceuticals, and technology. Her recent antitrust work has focused on alleged class-wide horizontal price-fixing conspiracy cases, including benchmark interest rates and consumer products.
Dr. Ginn’s experience also includes evaluations of alleged patent infringement in the pharmaceutical industry, analyses of vertical mergers, and responding to inquiries from domestic and international competition authorities. She has served as an economic expert witness in matters requiring statistical expertise, and has worked on several strategy cases in the technology and pharmaceutical industries, such as analyses of search advertising revenues.
Dr. Ginn’s experience also includes evaluations of alleged patent infringement in the pharmaceutical industry, analyses of vertical mergers, and responding to inquiries from domestic and international competition authorities. She has served as an economic expert witness in matters requiring statistical expertise, and has worked on several strategy cases in the technology and pharmaceutical industries, such as analyses of search advertising revenues.
